New Category III codes include minimally invasive valve, bone marrow procedures

Why This Topic Matters

Category III updates often signal emerging technologies and services that can affect reporting workflows, reimbursement review, and payer policy awareness. Knowing which specialties and code families are involved helps coding teams assess whether the article is relevant to their practice settings.

Article Sections

1. New Category III codes overview

   Introductory coverage of the new CPT Category III additions and the general clinical areas they affect. Also notes the source of the code list and the timing of availability.

2. Catheter-delivered prosthetic pulmonary valve

   Discussion of a minimally invasive cardiovascular procedure and the related reporting considerations mentioned in the article. The section also addresses associated component procedures and related separate-site services at a broad level.

3. Bone marrow cell therapy

   Overview of the new Category III codes tied to autologous bone marrow cell therapy for ischemia. Includes general discussion of the procedure components and related reporting limitations.

4. Carotid sinus baroreflex activation device

   Coverage of the device-related code family for treatment of resistant hypertension. The section summarizes the code group structure and notes the presence of bundling guidance.

5. Bundling instructions for CPT 0266T-0273T

   Additional reporting guidance associated with the carotid sinus baroreflex activation device code family. The section focuses on package and exclusion notes at a general level.

6. Percutaneous laminotomy/laminectomy

   Explanation of newly added spine procedure codes and the related minimally invasive decompression topic. Also mentions related open or endoscopic procedure families and a separate disc decompression code reference.

7. Payer coverage note

   General reminder that code presence does not guarantee coverage and that payer policies may differ. This section frames the article’s reporting updates in the context of reimbursement review.